A Sample Without a Manifest Is a Violation, Not a Visit
Most cannabis sales managers think of METRC as an operations problem — something the compliance team handles before product leaves the facility. That assumption breaks the moment a rep walks into a dispensary with samples in a bag.
Washington State made this explicit in April 2025. The Washington LCB's revised WAC 314-55-096 now requires that every trade sample be individually recorded in the state's traceability system, transported under a separate manifest from saleable inventory, and clearly labeled as "trade samples." Processors can provide up to 120 sample units per retailer per quarter. Break any one of those requirements and you haven't had a bad sales visit — you've generated a traceability gap that can trigger a license review. The Washington LCB's Compliance Information Bulletin 132 lays all of this out.
Washington is the sharpest current example, but not an outlier. Illinois completed its full migration from BioTrack to METRC on July 1, 2025. Every transfer — including samples — that isn't logged in METRC doesn't exist in the eyes of the regulator. California's Department of Cannabis Control is under court order to fix how METRC flags irregular transactions, meaning audit scrutiny on transfer records is increasing, not decreasing.
The compliance infrastructure is tightening across every major market. Sales reps are the last point of failure in the chain — and most brands haven't built their field operations to reflect that.
Why Reps Create METRC Risk Without Knowing It
The problem isn't that reps are cutting corners. It's that the sample workflow rarely gets the same operational attention as the order workflow.
Here's the typical failure pattern: a rep pulls samples from inventory without a formal transfer event, drives to three dispensaries, leaves product at each one, writes up a visit note, and moves on. Nothing illegal was intended. But from METRC's perspective, that product moved without a manifest. The audit trail has a gap.
In a state like Washington, where samples require a separate manifest from saleable product, this isn't a technicality — it's exactly what the rule was written to prevent. Processors are responsible for the traceability entry before the rep leaves the facility. If that entry doesn't exist, the visit shouldn't happen.
What the Field Process Actually Needs to Look Like
Compliance-safe sample distribution has to be built into the pre-visit workflow, not treated as a post-visit paperwork task.
Before a rep leaves for any account receiving a sample, the processor needs to have created a METRC transfer event with sample units itemized and the receiving retailer named. The rep carries the transport manifest and the retailer acknowledges receipt in METRC. The chain is complete.
That means reps need to know, before they arrive, exactly which accounts are getting samples, in what quantities, and for which SKUs. Improvised sampling — "I had an extra unit and left it at the counter" — is incompatible with traceability requirements in most METRC states.
From a CRM standpoint, this is where per-account visit notes matter beyond retail execution. Logging what samples were left, at which account, and who received them creates an internal record that can be reconciled against METRC data if a question arises. GreenPaths visit notes capture that detail at the account level — tied to the contact who received the sample, timestamped, and visible to the manager reviewing the route.
The Manager's Reporting Problem
Brands running multi-rep teams in METRC states have a specific oversight challenge: no real-time visibility into whether reps are following the sample manifest process until something goes wrong.
A compliance audit triggered by a traceability gap will surface every improper sample transfer that ever happened. "We didn't know" is not a defense — it's evidence of a supervision failure.
Managers need to build a sample distribution review into regular activity reporting: by account, by rep, by period — how many sample units were distributed, whether the corresponding METRC transfers were created, and what follow-up orders resulted. That last part matters beyond compliance: samples have a quarterly cap in Washington and likely will in other states as markets mature. If you can't tie sample spend to sales outcomes, you can't justify the budget.
GreenPaths manager dashboards let you pull visit activity and account-level notes by rep and territory. Pairing that internal record with your METRC transfer data gives you the reconciliation layer you need before an auditor asks for it.
Sampling Is Still Your Highest-ROI Field Activity — If You Run It Right
None of this means stop sampling. Budtender education and retailer sampling remain among the highest-ROI activities a cannabis brand can run, for exactly the reasons the cannabis retail staff education article on this blog covers. But the compliance burden is real and increasing.
The brands that survive tightening enforcement treat sample distribution with the same operational rigor they apply to sales orders: manifest before departure, documentation at the visit, manager visibility on outcomes, and reconciliation against traceability records as routine — not an emergency response.
If your current sample process is informal, that's the exposure. Fixing it is a sales operations decision as much as a compliance one. GreenPaths gives you the account and visit record layer that sits alongside your traceability system — capturing what happened in the field, tied to the right contacts, visible to the managers who need to see it.